Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 598

    1.

    Epigenetic regulation of RhoB loss of expression in lung cancer.

    Mazières J, Tovar D, He B, Nieto-Acosta J, Marty-Detraves C, Clanet C, Pradines A, Jablons D, Favre G.

    BMC Cancer. 2007 Nov 30;7:220.PMID: 18047684 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.

    J Natl Cancer Inst. 2006 Mar 15;98(6):396-406.PMID: 16537832 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.

    Sato N, Fukui T, Taniguchi T, Yokoyama T, Kondo M, Nagasaka T, Goto Y, Gao W, Ueda Y, Yokoi K, Minna JD, Osada H, Kondo Y, Sekido Y.

    Int J Cancer. 2007 Feb 1;120(3):543-51.PMID: 17096327 [PubMed - indexed for MEDLINE]Related articles

    4.

    Epigenetic down-regulation of death-associated protein kinase in lung cancers.

    Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, Padar A, Tockman MS, Lam S, Shivapurkar N, Gazdar AF.

    Clin Cancer Res. 2003 Aug 1;9(8):3034-41.PMID: 12912953 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line.

    Wang S, Yan-Neale Y, Fischer D, Zeremski M, Cai R, Zhu J, Asselbergs F, Hampton G, Cohen D.

    Oncogene. 2003 Sep 18;22(40):6204-13.PMID: 13679859 [PubMed - indexed for MEDLINE]Related articles

    6.

    Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.

    Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, Yoshie O, Ito H.

    Jpn J Cancer Res. 2001 Sep;92(9):947-51.PMID: 11572762 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.

    Zhong S, Fields CR, Su N, Pan YX, Robertson KD.

    Oncogene. 2007 Apr 19;26(18):2621-34. Epub 2006 Oct 9.PMID: 17043644 [PubMed - indexed for MEDLINE]Related articles

    8.

    Epigenetic inactivation of laminin-5-encoding genes in lung cancers.

    Sathyanarayana UG, Toyooka S, Padar A, Takahashi T, Brambilla E, Minna JD, Gazdar AF.

    Clin Cancer Res. 2003 Jul;9(7):2665-72.PMID: 12855645 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.

    Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T, Gazdar AF.

    Ann Surg Oncol. 2007 Apr;14(4):1397-404. Epub 2006 Dec 29.PMID: 17195088 [PubMed - indexed for MEDLINE]Related articles

    10.

    Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.

    Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W, Siegfried JM, Yu J, Zhang L.

    Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4336-44.PMID: 17671114 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues.

    Wang R, An J, Ji F, Jiao H, Sun H, Zhou D.

    Biochem Biophys Res Commun. 2008 Aug 15;373(1):151-4. Epub 2008 Jun 12.PMID: 18555005 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.

    Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF.

    Int J Cancer. 2003 Aug 20;106(2):198-204.PMID: 12800194 [PubMed - indexed for MEDLINE]Related articles

    13.

    Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.

    Nakano H, Nakamura Y, Soda H, Kamikatahira M, Uchida K, Takasu M, Kitazaki T, Yamaguchi H, Nakatomi K, Yanagihara K, Kohno S, Tsukamoto K.

    Cancer. 2008 Mar 1;112(5):1122-30.PMID: 18219662 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.

    Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.

    Mol Carcinog. 2003 Dec;38(4):170-8.PMID: 14639656 [PubMed - indexed for MEDLINE]Related articles

    15.

    Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

    Oncogene. 2005 Nov 24;24(53):7946-52.PMID: 16007117 [PubMed - indexed for MEDLINE]Related articles

    16.

    Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

    Horswill MA, Narayan M, Warejcka DJ, Cirillo LA, Twining SS.

    Exp Eye Res. 2008 Apr;86(4):586-600. Epub 2008 Jan 12.PMID: 18291368 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.

    Lee SH, Kim J, Kim WH, Lee YM.

    Oncogene. 2009 Jan 15;28(2):184-94. Epub 2008 Oct 13.PMID: 18850007 [PubMed - indexed for MEDLINE]Related articles

    18.

    RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

    Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF, Minna JD.

    Cancer Res. 2004 May 1;64(9):3137-43.PMID: 15126351 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.

    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.

    Mol Carcinog. 2005 Dec;44(4):233-41.PMID: 16163707 [PubMed - indexed for MEDLINE]Related articles

    20.

    Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.

    Wang SH, Liu NH, Wang J, Bai H, Mao L.

    Chin Med J (Engl). 2008 Sep 5;121(17):1712-21.PMID: 19024105 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination